Tecocraft Infusion Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -18.50%
- Profit Growth -45.07%
- Ebitda -21.32%
- Net Worth 41.96%
- Total Assets -1.75%
About Tecocraft Infusion
Tecocraft Infusion Private Limited (TIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 February 2018 (Six years and 11 months 18 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parth Vora, Hiralben Gondaliya, Kishan Gondaliya, and One other member serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2018PTC100946
-
Company No.
100946
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Tecocraft Infusion?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parth Vora
|
Director | 22-Feb-2018 | Current |
|
Hiralben Gondaliya
|
Director | 22-Feb-2018 | Current |
|
Kishan Gondaliya
|
Director | 02-Dec-2019 | Current |
|
Yagneshkumar Gondaliya
|
Director | 22-Feb-2022 | Current |
Financial Performance of Tecocraft Infusion.
Tecocraft Infusion Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.5% decrease. The company also saw a substantial fall in profitability, with a 45.07% decrease in profit. The company's net worth Soared by an impressive increase of 41.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tecocraft Infusion?
In 2022, Tecocraft Infusion had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Firmhealth Private LimitedParth Vora is a mutual person
-
Appstonelab Technologies Llp
Hiralben Gondaliya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tecocraft Infusion?
Tecocraft Infusion has a workforce of 12 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tecocraft Infusion, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tecocraft Infusion's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.